BREAKING NEWS!

Governor of Maryland visits India - Meets Shreis Scalene Sciences' partner Dr. Rajah Vijay Kumar.  

Shreis Scalene Sciences LLC engages Germantown, MD based Amarex CRO as its regulatory consultants.  

Prof. Meena Augustus Ph.D , co-founder and CSO of Shreis Scalene Sciences LLC takes over as CEO of the company.   Prof. Augustus will also continue to serve the company as its Chief Scientific Officer.

Subhash Mendonca will serve Shreis Scalene Sciences as the VP for Business Development

Shreis Scalene Sciences LLC (USA) awarded US Government IRS-Qualifying Therapeutic Discovery Project Program (QTDP) Grant under section 48D of Internal Revenue Code for:

"The Cytotron - a novel, stand alone therapeutic deice utilizing non-ionizing Rotational Field Quantum Magnetic Resonance to treat cancer AND  To Improve Drug Targeting & delivery through Nano-Permeabilization "

*Shreis Scalene Sciences LLC (USA) partners with Organization de Scalene and Scalene Greenergy Corporation, Bangalore, India to launch new company Shreis Scalene Greenergy LLC. (ss-greenergy.com)

New Developments - October 2010

   Cytotron developed by Scalene Cybernetics at its S-CARD campus, Bangalore, India, receives Chinese Patent

   Shreis Scalene Sciences signs license agreement with Technology Partner Scalene Cybernetics Bangalore,India for the use of Cytotron in the treatment of Multiple Sclerosis.  Clinical Trial registered with NIH ClinicalTrials.gov Identifier: NCT01220830

   Shreis Scalene Sciences  signs license agreement with Technology Partner Scalene Cybernetics Bangalore, India for the use of Cytotron in the treatment of cancer using Focused Resonance Nano Permeabilization  (FORN) -

(WO/2010/106544) A METHOD AND APPARATUS FOR - FOCUSED RESONANCE NANOPERMEABILIZATION (FORN)

   Shreis Scalene Sciences  signs MOU for $2 Million with Premier Diagnostic Health Services (http://premierdiagnostics.ca/) for supply and installation of a Cytotron and Canadian market operations for cancer treatment.

In The News